This observation supports the role of CD39+ T cells in preventing the development of MS [105,106,107], which is supported by evidence showing CD39 as one of the master regulators of Treg cells induced by the host microbiome [108]. This evidence concerns the gene ENTPD1 and myeloid sarcoma.